Their main business is HIV testing, they went public to expand on that. COVID is short term for them. They are ramping up production capacity to supply more HIV testing and expand in to other areas due to the success of the two devices they make. They have said they have currently sold their on hand stock and plan to triple production by August and x 10 by 2021. They were planning to go public before COVID and will still continue to expand post COVID. IMO from listening to the 23 min interview with the founder.
AT1 Price at posting:
46.5¢ Sentiment: Hold Disclosure: Held
